M&A Deal Summary |
|
|---|---|
| Date | 2018-05-15 |
| Target | Cord Blood America |
| Sector | Machinery |
| Buyer(s) | Generate Life Sciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Sector | Life Science |
| Revenue | 250M USD (2021) |
Generate Life Sciences is a life sciences company helping to grow and protect families through reproductive, newborn stem cell, genetic screening, medical device, and healthcare technology services. The company serves families from preconception to post-birth. Its brands CBR (Cord Blood Registry), California Cryobank, Donor Egg Bank USA, NW Cryobank, ReadyGen, Kitazato USA, and Donor Application are pioneering leaders that have helped nearly one million families. Headquartered in Los Angeles, Generate operates facilities in Tucson, New York, Boston, Palo Alto, and Rockville, MD.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Machinery) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (Nevada) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2018) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-02 |
Cell Care
Moorabbin, Australia Cell Care operates a purpose-built, state-of-the-art stem cell laboratory and storage facility. Cell Care is a family cord blood and tissue bank that has been collecting, processing, and storing cord stem cells for over ten years. Cell Care was founded in 2009 and is based in Moorabbin, Australia. |
Buy | - |
